A Presentation on Aminoglycoside
Antibiotic.
 Presented By:-
 Md. Ashraful Zaman Akash ID-131017
 Asraful Islam Rayhan ID-131039
 Md. Nazmus Sakib ID-131032
 Sanzida Afroze ID-131004
 Shamsunnahar Lipa ID-131021
 Md. Rubel Haque ID-131024
Dept. of PHARMACY
JESSORE UNIVERSITY OF SCIENCE & TECHNOLOGY.
Outline:-
 Antibiotics
 Aminoglycosides
-Mechanism of action
-Classification
-Pharmacokinetics
-Side Effect
 Streptomycin
 Gentamicin
 Neomycin
 Kanamycin
 Market Preparation
Antibiotics ?
What is aminoglycoside ?
Aminoglycosides are a group of antibiotics that are
effective against:
Aminoglycoside
(AGL)
Aerobic gram( - )bacteria
e.g.: pseudomonas,
Acinetobacter,
enterobacter
Some mycobacteria
e.g.:
bacteria that cause
tuberculosis
Some gram ( + ) bacteria
Characteristics of Aminoglycosides:-
 Formulations are Sulfate or hydrochloric salts
 Formulations are water soluble and stable
 Highly polar basic drugs.
 Ionize during dissolution
 Penetration through BBB is minimal
 Least metabolized by hepatic enzymes
 Excretion is mainly renal
Bactericidal in nature
More active in alkaline pH
MOA is by interfering with protein synthesis
Attach with 30S ribosomal subunit (ATT)
Mainly gram negative
Therapeutic index is narrow
Natural and semi-synthetic antibiotics
Characteristics of Aminoglycosides:-
Mechanism of action of AGL
Resistance against aminoglycosides
 Development and synthesis of plasmid mediated bacterial
transferase enzyme, which inactivates Aminoglycosides.
 Impaired active transport
 Inactivating enzymes in the cell membrane & inactivate
Aminoglycosides
 Aminoglycoside can not bind at target ribosomal subunit
and site.
 Decreased affinity of ribosomal proteins for binding with
Aminoglycosides
Aminoglycoside
(AGL)
Stretomyces
Suffix -mycin
Streptomycin Paromomycin
Neomycin Tobramycin
Micromonospora
Suffix -micin
Gentamicin Amikacin
Netilmicin
Common Members of Aminoglycosides
Streptomycin
Streptomycin
Streptomycin is
discovered by the
American scientist
Harry Waxman in
1944
Harry Waxman
Source of Streptomycin :-
Streptomyces griseus
Streptomycin
• Narrow spectrum (Gram negative)
• Bacteriocidal (High dose)
• Bacteriostatic (Low dose)
• Resistance develops fast
Mechanism of action of Streptomycin
Streptomycin
Binds with 30s
ribosomal sub-unit
Block peptide
formation
Inhibit protein
synthesis
Indication of Streptomycin :-
 Pulmonary Tuberculosis
 Plague
 Dysentery
 SABE
 Urinary tract infection
 Respiratory tract infection
 Peritonitis & Meningitis
Contraindication of Streptomycin
1.Kidney disease 2.Disturbance of
hearing
Adverse effects of Streptomycin
1.Ototoxicity
2.Nephrotoxicity
3.Neurotoxity
4.Hypersensitivity
5.Superinfection
Gentamicin
Gentamicin
Gentamicin was
discovered by
G.Wagman in 1963.
G. Wagman
Source :-
Micromonospora purpurea
Gentamicin
 Broad spectrum
 Most commonly used Aminoglycosides
 Synergism with Beta lactams
 Activity decreases in presence of pus
 Use- Usually in combination with Penicillin, Cephalosporin
Structure of Gentamicin
Pharmacokinetics of Gentamicin
Indication of Gentamycin
 Bacteraemia & septicaemia
 Abdominal & pelvic sepsis
 Infected Burn
 Osteomyelitis
 Peritonitis
 Pneumonia
•Allergic responses
•Neuromuscular problems
•Rash
•Haemolytic anaemia
•Nerve damage
Adverse effects
Neomycin
Neomycin
Neomycin is also
discovered by the
American scientist
Harry Waxman in
1949.
Source:-
Streptomyces fradiae
 Neomycin is an aminoglycoside antibiotic found in
many topical medications such as creams, ointments,
and eyedrops.
 Poorly absorbed in GIT
 Excreted by the GIT.
Neomycin
Indication:-
 Topical preparation used in:-
1. Infected wounds
2. Infected burns
3. Infected ulcers
4. Infected dermatosis
 Oral preparation Used in:-
1. Surgery
2. Hepatic coma.
Kanamycin
 Highly Ototoxic
 Highly Nephrotoxic
 Narrow spectrum
 Rarely used now
 Second line anti-tubercular drug
Amikacin
Amikacin
 Semi-synthetic derivative of Kanamycin
 Resistant is less
 Widest spectrum
 Reserve drug as alternate to Gentamicin
 More hearing loss
Tobramycin
 More active against Pseudomonas
and Proteus
 Reserve alternative of Gentamicin
Sisomicin:-
Obtained from Micromonospora
Same as gentamicin
Greater efficacy against
Pseudomonas
Special concern in treatment:-
Special concern in treatment:-
 Tobramycin is superior to gentamicin for treatment of
P.aeruginosa .
 Gentamicin is the preferred AGL used in combination treatment of
enterococcal endocarditis.
 Streptomycin has the greatest activity of all the AGL against
M.tuberculosis.
 Capreomycin is an AGL use as alternative drug to treat of
mycobacterial infection
 Streptomycin & gentamicin are drugs of choice to treat tularemia
 Streptomycin is drug of choice to treat plague & brucellosis
Patient counseling :
 Do not take AGL if you are pregnant or could become pregnant during
treatment.
 Do not take AGL if you are breast-feeding a baby.
 Take each dose with a full glass of water.
 Take AGL with food.
 Store AGL at room temperature away from moisture, heat, and direct light.
Available dosage form
( all aminoglycosides have very poor
absorption from G.I.T )
Dose regimen
(if creatinine clerance > 90ml/min)
Drug
I.V , I.MI.V
25-30 mg/weak ( tuberculosis )Streptomycin
OralOral
500 mgParomomycin
Oral , topical
It is not given intravenously, as it is extremely
nephrotoxic
Oral
For hepatic encephalopathy :
4-12 gm/d
As prophylactic in GI surgery :
1.0 gm po x3 with erythromycin
Neomycin
I.V , I.M , inhalationI.V
5.1 ( if critically ill ) mg/kg q24hTobramycin
I.V , I.M , Topical
I.V
5.1 ( if critically ill ) mg/kg q24hGentamicin
I.V , I.M
I.V
15mg/kg q24hAmikacin
I.V , I.M
The lowest ototoxic AGL
I.V
6.5 mg/kg q24hNetilmicin
Market Preparation of aminoglycosidic
Drug
IN
Bangladesh
Market Preparation Of Streptomycin
 Brand Name:- Streptopen (Renata Pharma Ltd.)
 Dose:- Streptomycin 1gm/vial
 Dosage Form :- Injection
Market Preparation Of Gentamicin
Market Preparation Of Neomycin
Market Preparation Of Amikacin
Aminoglycosides Antibiotic

Aminoglycosides Antibiotic